Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment

British Journal of Pharmacology

Volumn 132, Issue 4, 2001, Pages 909-917

  Cottet Maire, Florence ^a   Avdonin, Pavel V ^b   Roulet, Emmanuelle ^a   Buetler, Timo M ^a   Mermod, Nicolas ^a   Ruegg, Urs T ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

Author keywords

Cyclosporin A; Hypertension; mRNA stability; Promoter; Quantitative polymerase chain reaction; Receptor internalization; Receptor upregulation; Reporter gene assay; Smooth muscle cells

Indexed keywords

CALCINEURIN; CYCLOPHILIN; CYCLOSPORIN A; MESSENGER RNA; RECEPTOR SUBTYPE; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; ARGIPRESSIN; CYCLOSPORIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HNRNP D0; IMMUNOSUPPRESSIVE AGENT; RNA BINDING PROTEIN; VASOPRESSIN RECEPTOR;

ANIMAL CELL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; GENE EXPRESSION REGULATION; GLOMERULUS FILTRATION; HALF LIFE TIME; HYPERTENSION; INTERNALIZATION; MALE; NEPHROTOXICITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR UPREGULATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; UPREGULATION; WISTAR KYOTO RAT;

ANIMALS; ARGININE VASOPRESSIN; CELLS, CULTURED; CYCLOSPORINE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; IMMUNOSUPPRESSIVE AGENTS; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED WKY; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; RNA-BINDING PROTEINS; UP-REGULATION;

EID: 0034745986     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703878     Document Type: Article

References (49)

1. Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat
2. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line
3. Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin A-induced hypertension
4. Regulated mRNA stability
5. Endothelial and vascular smooth muscle function after chronic treatment with cyclosporin A
6. Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells
7. Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates
8. In vivo pharmacological effects of ciclosporin and some analogues
9. Demonstration of processing and recycling of biologically active VI vasopressin receptors in vascular smooth muscle
10. Effects of ANG II. ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction
11. Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line
12. Vasopressin messenger ribonucleic acid regulation via the protein kinase A pathway
13. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders
14. Cyclosporins. Structure-activity relationships
15. Cyclosporine augments renal but not systemic vascular reactivity
16. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs
17. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts
18. Preventive effects of diltiazem on cyclosporin A-induced vascular smooth muscle dysfunction
19. Prolyl isomerase requirement for the expression of functional homooligomeric ligand-gated ion channels
20. Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homooligomeric receptor expression
21. Cyclosporine
22. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin
23. Cyclosporine augments reactivity of isolated blood vessels
24. Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: Possible lack of relationship to immunosuppressive activity
25. Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A
26. Calcineurin enhances acetylcholinesterase mRNA stability during C2-C12 muscle cell differentiation
27. 1-receptor) response to arginine-vasopressin
28. Difference between aortic and renal vascular reactivity in cyclosporin A treated rats and the effect of cicletanine
29. Studies on the role of vasopressin in blood pressure control of spontaneously hypertensive rats with established hypertension (SHR, stroke-prone strain)
30. 2 arginine vasopressin receptors
31. 1a arginine vasopressin receptor
32. Structure of the rat V1a vasopressin receptor gene and characterization of its promoter region and complete cDNA sequence of the 3′-end
33. 1a vasopressin receptor expression by increasing mRNA stability in vascular smooth muscle cells
34. 1 receptor gene expression by posttranscriptional mechanisms
35. Characterization of the binding of the RNA-binding protein AUF1 to the human AT(1) receptor mRNA
36. Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway
37. Vasopressin and angiotensin II receptors in rat aortic smooth muscle cells in culture
38. Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells
39. Hypertension and insulin resistance
40. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506
41. Transcription factors of the NFAT family: Regulation and function
42. Control of messenger RNA stability in higher eukaryotes
43. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin
44. Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line
45. Cyclosporine-induced hypertension after transplantation
46. 1-vascular vasopressin receptors
47. Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction
48. Studies on the mechanisms of glucocorticoid hypertension in humans
49. 2+ signalling in a human vascular smooth muscle cell line